Fierce Biotech Fundraising Tracker '26: Celea raises $180M for phase 3 study of PureTech IPF drug

Biotech venture capital roundup: Osanni Bio leads with $190M Series B

A roundup of recent venture capital financings in the biotech sector, headlined by Osanni Bio's $190 million Series B round to fund drug can

Germany’s Merck Pumps Up Life Sciences Biz with $11.3B Bio-Techne Deal

European Tech Funding Roundup: NEURA Robotics raises $1.4B, 65+ deals worth €2.8B tracked this week

A weekly roundup of European tech funding news, highlighting over 65 deals worth €2.8 billion and 10+ exits/M&A transactions. Key featured s

RQ Bio secures $115M Series A for virus-targeting antibody pipeline

Coinbase CEO Brian Armstrong's Biotech Startup Newlimit Raises $435M, Valuation Triples to $3.1B

Newlimit, the longevity biotech co-founded by Coinbase CEO Brian Armstrong, raised $435 million in a Series C round led by Founders Fund, tr

Sector Snapshot: Cleantech Startup Funding Stabilizes As Energy Demand Grows

Sector Snapshot: Cleantech Startup Funding Stabilizes As Energy Demand Grows